Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 8/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 8/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.52 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.52 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.52 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.52 |
| ▸ | HTR1A | P08908 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | PGR | P06401 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.48 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14742426 | 0.87 | ADRA2A (0.55) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL8218840 | 0.82 | ADRA2A (0.50) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL30338047 | 0.82 | SLC22A6 (0.38) | LMNASMN1; SMN2 | |
| SCHEMBL1683105 | 0.81 | CHRM1 (0.55) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Hydrochloric Acid SCHEMBL26985533 | 0.80 | CHRM1 (0.35) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Hydrochloric Acid SCHEMBL27131488 | 0.80 | CHRM1 (0.35) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Acetylcholine SCHEMBL17629404 | 0.80 | CHRM1 (0.58) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL6034400 | 0.79 | CHRM1 (0.50) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL2530101 | 0.79 | CHRM1 (0.53) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL1075213 | 0.79 | HCAR2 (0.39) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5124061-A | Systemic plant cryoprotection with choline salts | GEARY SR ROBERT J (US) | 1992-06-23 | — | — | US | claimed |
| US-12305213-B2 | High gravity, fed-batch ionic liquid based process for deconstructing biomass | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2025-05-20 | — | — | US | disclosed |
| US-20240226045-A9 | RUMEN-PROTECTED COMPOSITIONS AND METHODS OF MAKING THE SAME | BALCHEM CORPORATION | 2024-07-11 | — | — | US | disclosed |
| WO-2024092005-A2 | RUMEN-PROTECTED COMPOSITIONS AND METHODS OF MAKING THE SAME | BALCHEM CORPORATION (US) | 2024-05-02 | — | — | WO | disclosed |
| US-20240130991-A1 | RUMEN-PROTECTED COMPOSITIONS AND METHODS OF MAKING THE SAME | BALCHEM CORP (US) | 2024-04-25 | — | — | US | disclosed |
| CN-116725015-A | Application of exogenous choline aspartic acid in improving corn yield | 西北农林科技大学 | 2023-09-12 | — | — | CN | disclosed |
| US-20220170053-A1 | HIGH GRAVITY, FED-BATCH IONIC LIQUID BASED PROCESS FOR DECONSTRUCTING BIOMASS | UNITED STATES DEPARTMENT OF ENERGY | 2022-06-02 | — | — | US | disclosed |
| US-11118197-B2 | High gravity, fed-batch ionic liquid based process for deconstructing biomass | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2021-09-14 | — | — | US | disclosed |
| US-20180346938-A1 | HIGH GRAVITY, FED-BATCH IONIC LIQUID BASED PROCESS FOR DECONSTRUCTING BIOMASS | UNITED STATES DEPARTMENT OF ENERGY | 2018-12-06 | — | — | US | disclosed |
| EP-1660017-A2 | AMINO ACID PRODRUGS | Signature R&D Holdings, LLC (US) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005046575-A2 | AMINO ACID PRODRUGS | SIGNATURE R & D HOLDINGS, LCC (US) | 2005-05-26 | — | — | WO | disclosed |